Formulation optimization of meloxicam sodium gel using response surface methodology
Authors:
- Yaw-Bin HuangYHYaw-Bin Huang
- Sen-Sen HouSHSen-Sen Hou
- Ren-Jiunn WangRWRen-Jiunn Wang
- Pao-Chu WuPWPao-Chu Wu
- Yi-Hung TsaiYTYi-Hung Tsai
- 1 June 2007
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 338 (1-2) , 48-54
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Solubility enhancement of cox-2 inhibitors using various solvent systemsAAPS PharmSciTech, 2003
- Local Tissue Tolerability of Meloxicam, a New NSAID: Indications for Parenteral, Dermal and Mucosal AdministrationRheumatology, 1996
- Pharmacology of Meloxicam, A New Non-Steroidal Anti-Inflammatory Drug with an Improved Safety Profile Through Preferential Inhibition of COX-2Rheumatology, 1996
- MeloxicamDrugs, 1996
- Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion/spheronizationInternational Journal of Pharmaceutics, 1995
- A new enhancer-coenhancer system to increase skin permeation of morphine hydrochloride in vitroInternational Journal of Pharmaceutics, 1993
- Surfactant effects in percutaneous absorption I. Effects on the transdermal flux of methyl nicotinateInternational Journal of Pharmaceutics, 1992
- Novel computer optimization methodology for pharmaceutical formulations investigated by using sustained-release granules of indomethacin.Chemical and Pharmaceutical Bulletin, 1989
- Increased Skin Permeability for Lipophilic MoleculesJournal of Pharmaceutical Sciences, 1984